Physician profile
Travis Bailey
NPI 1205280591
$1,255.77
in general payments reported to CMS, 2019-2025
11 companies · $525 in 2025
The $525 reported for 2025 was more than what 81% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2021: $131 · 2022: $132 · 2023: $61.51 · 2024: $223 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $269.45 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $259.13 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $223.85 | 2022-2025 | Miebo, Infuse |
| Harrow Eye, LLC | $125.00 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $116.15 | 2024 | |
| Kala Pharmaceuticals, INC. | $112.37 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.26 | 2019 | |
| Alcon Vision LLC | $46.45 | 2019 | |
| Optos, INC. | $18.78 | 2021 | |
| Tearlab Corp | $16.85 | 2022 | |
| Visioneering Technologies, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.